Pacific Sun Financial’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-8,615
| Closed | -$203K | – | 179 |
|
|
2024
Q4 | $203K | Sell |
8,615
-4,807
| -36% | -$113K | 0.11% | 178 |
|
|
2024
Q3 | $344K | Sell |
13,422
-1,495
| -10% | -$38.3K | 0.19% | 138 |
|
|
2024
Q2 | $350K | Sell |
14,917
-2,555
| -15% | -$60K | 0.21% | 130 |
|
|
2024
Q1 | $502K | Sell |
17,472
-1,280
| -7% | -$36.8K | 0.29% | 108 |
|
|
2023
Q4 | $615K | Sell |
18,752
-6,029
| -24% | -$198K | 0.39% | 78 |
|
|
2023
Q3 | $690K | Sell |
24,781
-3,625
| -13% | -$101K | 0.48% | 63 |
|
|
2023
Q2 | $854K | Buy |
+28,406
| New | +$854K | 0.57% | 56 |
|
|
2022
Q4 | $818K | Sell |
28,966
-4,730
| -14% | -$134K | 0.58% | 56 |
|
|
2022
Q3 | $1.11M | Sell |
33,696
-1,070
| -3% | -$35.2K | 0.78% | 38 |
|
|
2022
Q2 | $1.1M | Sell |
34,766
-1,837
| -5% | -$57.9K | 0.72% | 39 |
|
|
2022
Q1 | $1.68M | Buy |
36,603
+1,406
| +4% | +$64.6K | 0.92% | 30 |
|
|
2021
Q4 | $2.16M | Buy |
35,197
+785
| +2% | +$48.1K | 1.15% | 23 |
|
|
2021
Q3 | $2.57M | Buy |
+34,412
| New | +$2.57M | 1.48% | 13 |
|
|
2020
Q3 | $1.17M | Buy |
18,367
+2,482
| +16% | +$158K | 0.98% | 29 |
|
|
2020
Q2 | $829K | Buy |
15,885
+420
| +3% | +$21.9K | 0.75% | 46 |
|
|
2020
Q1 | $484K | Buy |
15,465
+6,390
| +70% | +$200K | 0.56% | 66 |
|
|
2019
Q4 | $304K | Buy |
9,075
+1,130
| +14% | +$37.9K | 0.27% | 109 |
|
|
2019
Q3 | $235K | Buy |
+7,945
| New | +$235K | 0.22% | 119 |
|